AstraZeneca PLC (AZN) Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation TranscriptSeeking Alpha • 07/06/26
Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial ClearanceBenzinga • 07/02/26
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLCPRNewsWire • 07/02/26
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)Zacks Investment Research • 07/01/26
Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readoutProactive Investors • 06/26/26
For decades, the only first treatment for one of the deadliest breast cancers was standard chemotherapy. Now there are two newly approved drugs.WSJ • 06/24/26
AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer CareBusiness Wire • 06/24/26
The U.S. has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffsWSJ • 06/19/26
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 06/18/26
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?Zacks Investment Research • 06/16/26